RNF222

gene
On this page

Summary

RNF222 (ring finger protein 222, HGNC:34517) is a protein-coding gene on chromosome 17p13.1, encoding RING finger protein 222 (A6NCQ9).

Predicted to enable zinc ion binding activity. Predicted to be located in membrane.

Source: NCBI Gene 643904 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 52 total
  • MANE Select transcript: NM_001146684

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:34517
Approved symbolRNF222
Namering finger protein 222
Location17p13.1
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000189051
Ensembl biotypeprotein_coding
Entrez643904

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000344001, ENST00000399398

RefSeq mRNA: 1 — MANE Select: NM_001146684 NM_001146684

CCDS: CCDS45608

Canonical transcript exons

ENST00000399398 — 3 exons

ExonStartEnd
ENSE0000153796783907028393486
ENSE0000153796883941788394329
ENSE0000153796983976958397827

Expression profiles

Bgee: expression breadth broad, 29 present calls, max score 92.60.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0414 / max 6.9722, expressed in 15 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1644320.041415

Top tissues by expression

119 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
lower esophagus mucosaUBERON:003583492.60gold quality
esophagus mucosaUBERON:000246978.83gold quality
skin of legUBERON:000151172.78gold quality
zone of skinUBERON:000001472.25gold quality
skin of abdomenUBERON:000141671.72gold quality
vaginaUBERON:000099660.69gold quality
esophagusUBERON:000104357.08gold quality
tonsilUBERON:000237255.33gold quality
placentaUBERON:000198752.60gold quality
bone marrowUBERON:000237152.37gold quality
bone marrow cellCL:000209249.73gold quality
ectocervixUBERON:001224947.09gold quality
uterine cervixUBERON:000000246.67gold quality
bloodUBERON:000017846.44silver quality
granulocyteCL:000009442.94silver quality
minor salivary glandUBERON:000183042.91gold quality
skeletal muscle tissueUBERON:000113442.30gold quality
endometriumUBERON:000129542.25gold quality
saliva-secreting glandUBERON:000104442.24gold quality
sural nerveUBERON:001548842.10gold quality
colonic epitheliumUBERON:000039742.04gold quality
lymph nodeUBERON:000002941.19gold quality
cortical plateUBERON:000534339.79gold quality
ganglionic eminenceUBERON:000402338.83gold quality
vermiform appendixUBERON:000115438.73silver quality
muscle tissueUBERON:000238538.71gold quality
multicellular organismUBERON:000046837.85gold quality
urinary bladderUBERON:000125536.68gold quality
liverUBERON:000210736.58gold quality
ventricular zoneUBERON:000305336.48gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.43

Regulation

Is transcription factor: no

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusRnf222ENSMUSG00000046490
rattus_norvegicusRnf222ENSRNOG00000022964

Protein

Protein identifiers

RING finger protein 222A6NCQ9 (reviewed: A6NCQ9)

All UniProt accessions (1): A6NCQ9

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

RefSeq proteins (1): NP_001140156* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001841Znf_RINGDomain
IPR013083Znf_RING/FYVE/PHDHomologous_superfamily
IPR017907Znf_RING_CSConserved_site
IPR027370Znf-RING_eukDomain
IPR042973RNF222Family

Pfam: PF13445

UniProt features (5 total): chain 1, transmembrane region 1, zinc finger region 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A6NCQ9-F163.130.10

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 40 (showing top): ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GSE13522_WT_VS_IFNG_KO_SKIN_UP, SKP2_TARGET_GENES, MIR4728_5P, MIR6785_5P, MIR182_5P, MIR149_3P, MIR6883_5P, MIR3182, MIR6887_3P, MIR4653_5P, MIR3921, MIR337_3P, MIR4667_3P, MIR1301_3P_MIR5047

GO Biological Process (0):

GO Molecular Function (2): zinc ion binding (GO:0008270), metal ion binding (GO:0046872)

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transition metal ion binding1
cation binding1
cellular anatomical structure1

Protein interactions and networks

STRING

154 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RNF222SEZ6LQ9BYH1574
RNF222TMEM220Q6QAJ8526
RNF222ZZEF1O43149477
RNF222SAMD1Q6SPF0471
RNF222PI15O43692455
RNF222CUZD1Q86UP6432
RNF222MUC15Q8N387425
RNF222GABRPO00591414
RNF222GABRDO14764399
RNF222NUP210Q8TEM1398
RNF222OLFML2BQ68BL8394
RNF222DMGDHQ9UI17365
RNF222BACE2Q9Y5Z0356
RNF222ANP32EQ9BTT0325
RNF222RMI2Q96E14318

IntAct

0 interactions, top by confidence:

BioGRID (1): RNF222 (Affinity Capture-MS)

ESM2 similar proteins: A6NCL7, A6NCQ9, A6QP29, A6QQV9, B1AVH7, B5DFA1, D2H0G5, D2H6Z0, D2H788, D3ZBM4, D4A723, E1C2W7, O95153, Q0QWG9, Q3SWY0, Q3T0Y9, Q3U0L2, Q3UV31, Q3V3A7, Q5RF77, Q60943, Q6INB3, Q6PGG2, Q7TNF8, Q7Z465, Q80TI1, Q810L3, Q8BG47, Q8BRJ3, Q8BXP5, Q8C0R7, Q8C432, Q8CEF8, Q8HYZ0, Q8N0U2, Q8N6D2, Q8N8N0, Q8NC24, Q8QZS5, Q8TED9

Diamond homologs: A6NCQ9, E7ERA6, M0QZC1, Q3UV31, Q6ZWI9, Q8CEF8, Q9D7D1, P0DH78, Q13049, Q3SWY0, Q3UIW8, Q8CH72, Q8QZS5, Q96D59, E1BD59, O16616, Q5ZMD4, Q6VVB1, Q8IWR1, Q922Y2, Q9BRZ2, Q9D241, Q5E9G4, Q5M929

SIGNOR signaling

1 interactions.

AEffectBMechanism
Ub:E2“up-regulates activity”RNF222ubiquitination

Disease & clinical

Clinical variants and AI predictions

ClinVar

52 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance49
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

48 predictions. Top by Δscore:

VariantEffectΔscore
17:8392810:T:TAdonor_gain0.9300
17:8392801:ACG:Adonor_gain0.8100
17:8392802:CGC:Cdonor_gain0.8100
17:8392785:C:CAdonor_gain0.7900
17:8392811:C:Adonor_gain0.6300
17:8392810:TCCTC:Tdonor_gain0.5700
17:8393332:TG:Tdonor_gain0.5500
17:8392818:A:Tdonor_gain0.4700
17:8392814:C:Tdonor_gain0.4300
17:8392784:T:TAdonor_gain0.4100
17:8392802:CG:Cdonor_gain0.3800
17:8393026:C:CAdonor_gain0.3200
17:8392482:C:Aacceptor_gain0.3100
17:8392545:AGC:Aacceptor_loss0.3000
17:8392546:GCCT:Gacceptor_loss0.3000
17:8392547:CC:Cacceptor_loss0.3000
17:8392548:C:Aacceptor_loss0.3000
17:8392548:C:CCacceptor_gain0.3000
17:8392549:T:Aacceptor_loss0.3000
17:8392803:G:Cdonor_gain0.3000
17:8392550:A:Cacceptor_loss0.2900
17:8392852:C:CTdonor_gain0.2800
17:8392542:C:CTacceptor_gain0.2700
17:8392543:C:CGacceptor_gain0.2700
17:8392546:G:GAacceptor_gain0.2500
17:8392256:C:Aacceptor_gain0.2400
17:8392817:C:CTdonor_gain0.2300
17:8391333:T:Gacceptor_gain0.2200
17:8392137:CCCCT:Cacceptor_gain0.2200
17:8392541:TCC:Tacceptor_gain0.2200

AlphaMissense

1395 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:8393281:A:GC61R1.000
17:8393351:G:CF37L1.000
17:8393351:G:TF37L1.000
17:8393352:A:GF37S1.000
17:8393353:A:GF37L1.000
17:8393422:A:GC14R1.000
17:8393270:G:CC64W0.999
17:8393271:C:AC64F0.999
17:8393271:C:GC64S0.999
17:8393271:C:TC64Y0.999
17:8393272:A:GC64R0.999
17:8393272:A:TC64S0.999
17:8393279:G:CC61W0.999
17:8393280:C:GC61S0.999
17:8393280:C:TC61Y0.999
17:8393281:A:TC61S0.999
17:8393339:G:CC41W0.999
17:8393340:C:GC41S0.999
17:8393340:C:TC41Y0.999
17:8393341:A:GC41R0.999
17:8393341:A:TC41S0.999
17:8393348:G:CC38W0.999
17:8393349:C:TC38Y0.999
17:8393350:A:GC38R0.999
17:8393352:A:CF37C0.999
17:8393363:A:CC33W0.999
17:8393364:C:GC33S0.999
17:8393364:C:TC33Y0.999
17:8393365:A:GC33R0.999
17:8393365:A:TC33S0.999

dbSNP variants (sampled 300 via entrez): RS1000030344 (17:8391824 C>T), RS1000144632 (17:8391662 T>G), RS1000344784 (17:8397706 G>C), RS1000884238 (17:8394405 A>C), RS1001824361 (17:8391955 T>C,G), RS1002281783 (17:8398908 A>G), RS1002373338 (17:8393282 G>A), RS1002573977 (17:8398658 C>A,T), RS1002668639 (17:8397409 A>C), RS1002966863 (17:8391579 C>A,G,T), RS1003122392 (17:8396020 A>G), RS1003379897 (17:8394699 C>T), RS1003417716 (17:8395757 G>T), RS1003893042 (17:8398565 C>T), RS1004837665 (17:8391555 G>A)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

7 total (human), top 7 by PubMed support.

ChemicalActions (top 5)PubMed papers
Resveratrolaffects cotreatment, decreases expression1
Benzo(a)pyreneaffects methylation, decreases methylation, increases methylation1
Plant Extractsaffects cotreatment, decreases expression1
Tobacco Smoke Pollutionincreases expression1
Aflatoxin B1increases methylation1
Cadmium Chlorideincreases expression1
Lactic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.